MICURAPHARM
LIVE

Serial Number

79383833

Owner

MicuraPharm GmbH

Attorney

Jeffrey L. Wilson

Filing Date

Feb 28, 2023

Add to watchlist:

No watchlists yet
View on USPTO

MICURAPHARM Trademark

Serial Number: 79383833 • Registration: 7404353

MICURAPHARM is a trademark filed by MicuraPharm GmbH on February 28, 2023. The trademark is classified under Class 5 (Pharmaceuticals), Class 7 (Machinery), Class 10 (Medical Apparatus), Class 39 (Transportation & Storage), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 16 (Paper Goods), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

MicuraPharm GmbH

Auf dem Langloos 26

Entity Type: 99

Trademark Details

Filing Date

February 28, 2023

Registration Date

June 4, 2024

Published for Opposition

March 19, 2024

Goods & Services

Packaging machines; blistering packaging systems, namely, machines for the automatic patient-specific blister packaging of drugs; machines for blistering packaging of capsules and tablets

Blister packaging and packaging of drugs and pharmaceutical products for others; blister packaging of goods, in particular patient-specific blister packaging of drugs for others; advice regarding the blister packaging of medications; rental of equipment for patient specific blister packaging of medications; rental of equipment for patient-specific blister packaging of medications

Medical and veterinary preparations in the nature of diagnostic preparations for medical and veterinary use; hygiene products and articles for medical purposes, namely, disinfectants for hygiene purposes

Packaging materials of cardboard; plastic packaging material, as far as included in this class, namely, plastic film for use as packaging material for general use; packaging films of plastic or consisting predominantly of plastic combined with other materials, as far as included in this class, in particular for medicaments; blister packs; blister cards; Plastic sealing foils

Wholesale and retail store services featuring medical and hygiene products; wholesale and retail store services featuring personal protective equipment for care facilities and hospitals; retail or wholesale store services featuring medical, pharmaceutical, veterinary, and hygiene supplies; business management of logistics for others; mediation of contracts for the purchase and sale of software applications, in particular for intelligent patient-specific drug blistering; procurement of contracts for others for the purchase and sale of monitoring stations for patient monitoring

Medical services, especially for patient monitoring in connection with medication intake and movement patterns; medical services, namely, recording of vital parameters; medical services in connection with the operation of equipment for the automatic patient-specific blistering of medications; all the aforementioned services not in the field of home care services or medical care services

Protective clothing for medical purposes, namely, surgical scrub suits, surgical masks, medical masks, sanitary masks, visors for dental use, visors for surgical use, visors for veterinary use, gloves for medical use, nose masks for medical use, nose masks for veterinary use, nose masks for dental use, protective sleeves for medical use, bonnets for the hair for wear by dental, medical and veterinary practitioners; respirators for medical applications and their accessories in the nature of respirators for artificial respiration; apparatus and instruments for patient monitoring, in particular patient monitoring apparatus and monitoring stations for monitoring vital signs of patients and automated monitoring of patients intake of medication; apparatus and instruments for recording vital parameters in the nature of medical apparatus and instruments for monitoring vital signs and medication consumption and recorded software for recording medical data, for use therewith, sold as a unit; medical devices in the form of instruments, apparatus, appliances or other articles in this class which prevent, detect, monitor or alleviate disease, namely systems for patient monitoring to assist patients with medication consumption and the monitoring of patients vital parameters

Development of software applications, especially for intelligent patient-specific drug blistering; development of monitoring stations for patient monitoring; technical product development of medical and hygiene products; technical product development of personal protective equipment for care facilities and hospitals

Filing History

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
May 9, 2025 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 22, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Apr 22, 2025 OPNR
FINAL DECISION TRANSACTION PROCESSED BY IB
Dec 7, 2024 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Nov 20, 2024 FICS
FINAL DISPOSITION PROCESSED
Nov 20, 2024 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Sep 4, 2024 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jun 4, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Jun 4, 2024 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 19, 2024 NPUB
PUBLISHED FOR OPPOSITION
Mar 19, 2024 PUBO
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 28, 2024 NPUB
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 28, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 13, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 27, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 26, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 26, 2024 TROA
REFUSAL PROCESSED BY IB
Jan 8, 2024 RFNT
CHANGE OF NAME/ADDRESS REC'D FROM IB
Jan 6, 2024 ADCH
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Dec 14, 2023 RFCS
REFUSAL PROCESSED BY MPU
Dec 14, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Dec 6, 2023 RFCR
NON-FINAL ACTION WRITTEN
Dec 5, 2023 CNRT
APPLICATION FILING RECEIPT MAILED
Dec 1, 2023 MAFR
ASSIGNED TO EXAMINER
Nov 29, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 27, 2023 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Nov 23, 2023 REPR